Mylan pays $17.5 million for Pfizer’s copy of Advair

by PharmaTimes | 1st Jan 2000 | News

Tags

Related posts

Bayer begins phase 2 trial of new Alport syndrome therapy

Bayer begins phase 2 trial of new Alport syndrome therapy

Dec 4, 2025

Johnson & Johnson wins EU approval for new gMG treatment

Johnson & Johnson wins EU approval for new gMG treatment

Dec 4, 2025

Pharvaris reports positive phase 3 results for HAE treatment

Pharvaris reports positive phase 3 results for HAE treatment

Dec 3, 2025

AlzeCure secures EU grant for Alzheimer’s drug trial

AlzeCure secures EU grant for Alzheimer’s drug trial

Dec 3, 2025

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999